Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial Board

    Page :i

    

• Evidence-Based Review

  • ·Role of physiotherapy in the management of chronic lung diseases: An overview of systematic reviews

    Page :2429-2436

    Rachel Garrod, Toby Lasserson

    Résumé Résumé Plan Plan  

• Original Articles

  • ·Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone

    Page :2437-2446

    Jean Bousquet, Louis-Philippe Boulet, Matthew J. Peters, Helgo Magnussen, Joaquin Quiralte, Nora E. Martinez-Aguilar, Åsa Carlsheimer

    Résumé Résumé Plan Plan  
  • ·Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study

    Page :2447-2453

    M. Carone, A. Patessio, N. Ambrosino, P. Baiardi, B. Balbi, G. Balzano, V. Cuomo, C.F. Donner, C. Fracchia, S. Nava, M. Neri, E. Pozzi, M. Vitacca, A. Spanevello

    Résumé Résumé Plan Plan  
  • ·Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade

    Page :2454-2463

    Martijn A. Spruit, Herman-Jan Pennings, Paul P. Janssen, Joan D. Does, Sigrid Scroyen, Marco A. Akkermans, Rob Mostert, Emiel F.M. Wouters

    Résumé Résumé Plan Plan  
  • ·Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler^® in adult subjects with stable moderate-to-severe COPD

    Page :2464-2471

    B. Brashier, P. Dhembare, A. Jantikar, P. Mahadik, P. Gokhale, J.A. Gogtay, S.S. Salvi

    Résumé Résumé Plan Plan   
  • ·A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD

    Page :2472-2481

    Anastasia F. Hutchinson, Anil K. Ghimire, Michelle A. Thompson, Jim F. Black, Caroline A. Brand, Adrian J. Lowe, David M. Smallwood, Ross Vlahos, Steven Bozinovski, Graham V. Brown, Gary P. Anderson, Louis B. Irving

    Résumé Résumé Plan Plan   
  • ·Interrupter resistance short-term repeatability and bronchodilator response in preschool children

    Page :2482-2487

    Nicole Beydon, Célestin M’Buila, Aurélie Bados, Claudine Peiffer, Agnès Bernard, Isabelle Zaccaria, André Denjean

    Résumé Résumé Plan Plan  
  • ·Comparison of the efficacy of salmeterol/fluticasone propionate combination in Japanese and Caucasian asthmatics

    Page :2488-2494

    M. Kawai, R. Kempsford, T. Pullerits, S. Takaori, K. Hashimoto, Y. Takemoto, J. Lötvall

    Résumé Résumé Plan Plan  
  • ·Pulmonary arterial pulse pressure and mortality in pulmonary arterial hypertension

    Page :2495-2501

    Kevin G. Blyth, Raheel Syyed, James Chalmers, John E. Foster, Tarek Saba, Robert Naeije, Christian Melot, Andrew J. Peacock

    Résumé Résumé Plan Plan  
  • ·Hypogonadism in male outpatients with sarcoidosis

    Page :2502-2510

    Martijn A. Spruit, Michiel J. Thomeer, Rik Gosselink, Wim A. Wuyts, Erik Van Herck, Roger Bouillon, Maurits G. Demedts, Marc Decramer

    Résumé Résumé Plan Plan  
  • ·Costs of asthma in Italy: Results of the SIRIO (Social Impact of Respiratory Integrated Outcomes) study

    Page :2511-2519

    R.W. Dal Negro, C. Micheletto, R. Tosatto, M. Dionisi, P. Turco, C.F. Donner

    Résumé Résumé Plan Plan  
  • ·The prevalence of alpha₁-antitrypsin deficiency in a representative population sample from Poland

    Page :2520-2525

    Marcin P. Kaczor, Marek Sanak, Magdalena Libura-Twardowska, Andrew Szczeklik

    Résumé Résumé Plan Plan  
  • ·Novel clinical and serological aspects in non-allergic asthma

    Page :2526-2533

    A.L. Comi, A. Tedeschi, M. Lorini, A. Miadonna

    Résumé Résumé Plan Plan
  • ·The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK

    Page :2534-2540

    Ivan Le Jeune, Jonathan Gribbin, Joe West, Chris Smith, Paul Cullinan, Richard Hubbard

    Résumé Résumé Plan Plan
  • ·Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. : The Tromsø Study 2001

    Page :2541-2549

    Hasse Melbye, Dag S. Halvorsen, Ingeborg Hartz, Astri Medbø, Jan Brox, Anne Elise Eggen, Inger Njølstad

    Résumé Résumé Plan Plan  
  • ·Evaluation of sleep quality and anxiety–depression parameters in asthmatic children and their mothers

    Page :2550-2554

    Hasan Yuksel, Ayhan Sogut, Ozge Yilmaz, Murat Demet, Dilek Ergin, Cengiz Kirmaz

    Résumé Résumé Plan Plan  
  • ·Methacholine challenge in pre-school children—Which outcome measure?

    Page :2555-2560

    J. Kivastik, A.-M. Gibson, R.A. Primhak

    Résumé Résumé Plan Plan  

• Short Communication

  • ·N.U.A.G.E.S: A survey of nebulisation practice in France with regard to ERS guidelines

    Page :2561-2565

    M. de Monte, J. Scruignec, J.C. Dubus, J.P. Chaumuzeau, B. Dautzenberg, J.F. Dessanges, M.H. Becquemin, P. Diot, for the GAT †

    Résumé Résumé Plan Plan

• Letters to the Editor

  • ·Effect of freezing on exhaled breath condensate pH

    Page :2566

    Tamás Kullmann, Imre Barta, Ildikó Horváth

    
  • ·Reply to: Kullmann T, et al. Differences in exhaled breath condensate pH measurements obtained with two commercial devices

    Page :2567

    L. Prieto

    

• Corrigenda

  • ·Corrigendum to: “Factors related to tobacco use among teenagers” : [Respir Med 2007;101(3):496–502]

    Page :2568

    Linnéa Hedman, Anders Bjerg, Matthew Perzanowski, Sigrid Sundberg, Eva Rönmark

    
  • ·Corrigendum to: “Prevalence and underdiagnosis of COPD by disease severity and attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden Studies” : [Respir Med 2006;100(2):264–272]

    Page :2569

    Anne Lindberg, A. Bjerg, Eva Rönmark, Lars-Gunnar Larsson, Bo Lundbäck